e-learning
resources
Munich 2006
Tuesday 05.09.2006
Treatment and complications of treatment of lung cancer and malignant pleural effusions
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
An audit on an assistance pathway of the lung tumor
C. M. Carbonelli, R. Toffanetti, L. Agostini, L. Zucchi (Reggio Emilia, Italy)
Source:
Annual Congress 2006 - Treatment and complications of treatment of lung cancer and malignant pleural effusions
Session:
Treatment and complications of treatment of lung cancer and malignant pleural effusions
Session type:
Electronic Poster Session
Number:
4297
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. M. Carbonelli, R. Toffanetti, L. Agostini, L. Zucchi (Reggio Emilia, Italy). An audit on an assistance pathway of the lung tumor. Eur Respir J 2006; 28: Suppl. 50, 4297
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
No lung cancer at resection of PET positive lesions: an audit of the lung cancer multidisciplinary team
Source: Eur Respir J 2009; 33: 941-942
Year: 2009
The role of bronchoscopy in the diagnosis of lung cancer: an audit to assess standards
Source: Eur Respir J 2001; 18: Suppl. 33, 62s
Year: 2001
Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019
Nurse led lung cancer diagnostic/supportive follow up clinic;a different approach to optimise lung cancer pathway
Source: International Congress 2018 – The many facets of respiratory nursing
Year: 2018
Direct to surgery treatment of suspected lung cancer – results from a UK lung cancer multidisciplinary team (MDT)
Source: Virtual Congress 2021 – Innovation in thoracic surgery
Year: 2021
Patient perspectives and experience on the diagnostic pathway of lung cancer – a qualitative study
Source: International Congress 2018 – Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care
Year: 2018
Impact of a rapid access pathway for urgent referrals with suspected lung cancer and assessment of subsequent diagnoses
Source: Eur Respir J 2006; 28: Suppl. 50, 126s
Year: 2006
The UK timed diagnostic lung cancer pathway: a pleural disaster
Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside
Year: 2020
Retrospective review of a novel clinical service and pathway for patients with pulmonary nodules
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016
Improving standards in flexible bronchoscopy for lung cancer
Source: Eur Respir J 2011; 37: 895-901
Year: 2011
The ALA/ATS implementation guide on lung cancer screening
Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance!
Year: 2018
Multi-disciplinary team working in lung cancer; nature and outcome of discussions
Source: Eur Respir J 2006; 28: Suppl. 50, 750s
Year: 2006
Tumour growth rate as a tool for response evaluation during PD-1 treatment for non-small cell lung cancer: a retrospective analysis
Source: ERJ Open Res, 5 (4) 00179-2019; 10.1183/23120541.00179-2019
Year: 2019
Admitting lung cancer patients to intensive care for organ dysfunction: a complex decision process
Source: Eur Respir J 2015; 45: 308-309
Year: 2015
The role of a trained respiratory physician in lung cancer management
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008
Does a straight-to-CT pathway improve lung cancer patient waiting times?
Source: Annual Congress 2008 - Treatment of thoracic tumours
Year: 2008
Delays in lung cancer management
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005
Utilisation of biomarker testing to guide therapy in non-small cell lung cancer in a regional lung cancer service
Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Year: 2018
Gefitinib monotherapy in advanced nonsmall cell lung cancer: a large Western community implementation study
Source: Eur Respir J 2007; 29: 128-133
Year: 2007
A comparison of patients from a regional multi disciplinary team referred for surgical lung cancer treatment
Source: International Congress 2017 – Noteworthy lung cancer patient reports: reported outcome measures, smoking cessation, weight and sleep disorders
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept